Adding Cilostazol to Dual Antiplatelet Therapy Achieves Greater Platelet Inhibition than High Maintenance Dose Clopidogrel in Patients With Acute Myocardial Infarction-Reference-Cited by-同舟云学术

Adding Cilostazol to Dual Antiplatelet Therapy Achieves Greater Platelet Inhibition than High Maintenance Dose Clopidogrel in Patients With Acute Myocardial Infarction

Published:2010-02 Issue:1 Volume:3 Page:17-26
ISSN:1941-7640
Container-title:Circulation: Cardiovascular Interventions
language:en
Short-container-title:Circ Cardiovasc Interv

Author:

Jeong Young-Hoon¹,Hwang Jin-Yong¹,Kim In-Suk¹,Park Yongwhi¹,Hwang Seok-Jae¹,Lee Seung-Whan¹,Kwak Choong Hwan¹,Park Seong-Wook¹

Affiliation:

1. From the Division of Cardiology, Department of Internal Medicine (Y.-H.J., J.-Y.H., Y.P., S.-J.H., C.H.K) and Department of Laboratory Medicine (I.-S.K), Gyeongsang National University Hospital, Jinju, Korea; and Department of Medicine (S.-W.L., S.-W.P.), Asan Medical Center University of Ulsan College of Medicine, Seoul, Korea.

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine

Reference35 articles.

1. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study

2. Effect of Clopidogrel Pretreatment Before Percutaneous Coronary Intervention in Patients With ST-Elevation Myocardial Infarction Treated With FibrinolyticsThe PCI-CLARITY Study

3. The Relative Safety and Efficacy of Abciximab and Eptifibatide in Patients Undergoing Primary Percutaneous Coronary Intervention

4. Percutaneous Coronary Intervention in Patients Receiving Enoxaparin or Unfractionated Heparin After Fibrinolytic Therapy for ST-Segment Elevation Myocardial Infarction in the ExTRACT-TIMI 25 Trial

5. Drug-Eluting Stent and Coronary Thrombosis

Cited by 94 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The Role of Cilostazol, a Phosphodiesterase-3 Inhibitor, in the Development of Atherosclerosis and Vascular Biology: A Review with Meta-Analysis;International Journal of Molecular Sciences;2024-02-23

2. Triple Antiplatelet Therapy with Cilostazol and Favorable Early Clinical Outcomes after Acute Myocardial Infarction Compared to Dual Antiplatelet Therapy with Standard or Potent P2Y12 Inhibitors;Journal of Clinical Medicine;2022-11-21

3. Intensified antiplatelet therapy in patients after percutaneous coronary intervention with high on‐treatment platelet reactivity: the OPTImal Management of Antithrombotic Agents (OPTIMA)‐2 Trial;British Journal of Haematology;2021-10-05

4. Cilostazol: a Review of Basic Mechanisms and Clinical Uses;Cardiovascular Drugs and Therapy;2021-04-16

5. Anti-platelet Drug-loaded Targeted Technologies for the Effective Treatment of Atherothrombosis;Current Drug Targets;2021-03-10